MOESM1 of Effects of recombinant human growth hormone treatment on growth, body composition, and safety in infants or toddlers with Prader-Willi syndrome: a randomized, active-controlled trial

MLA

Yang, Aram, et al. MOESM1 of Effects of Recombinant Human Growth Hormone Treatment on Growth, Body Composition, and Safety in Infants or Toddlers with Prader-Willi Syndrome: A Randomized, Active-Controlled Trial. Jan. 2019. EBSCOhost, https://doi.org/10.6084/m9.figshare.9809417.v1.

APA

Yang, A., Choi, J.-H., Sohn, Y., Yunae Eom, Jiyoon Lee, Han-Wook Yoo, & Jin, D.-K. (2019). MOESM1 of Effects of recombinant human growth hormone treatment on growth, body composition, and safety in infants or toddlers with Prader-Willi syndrome: a randomized, active-controlled trial. https://doi.org/10.6084/m9.figshare.9809417.v1

Chicago

Yang, Aram, Jin-Ho Choi, Young Sohn, Yunae Eom, Jiyoon Lee, Han-Wook Yoo, and Dong-Kyu Jin. 2019. “MOESM1 of Effects of Recombinant Human Growth Hormone Treatment on Growth, Body Composition, and Safety in Infants or Toddlers with Prader-Willi Syndrome: A Randomized, Active-Controlled Trial,” January. doi:10.6084/m9.figshare.9809417.v1.